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Abstract: Seaweeds are a sustainable source of novel functional ingredients with applicability in
pharmaceutics, biotechnology, and food science. The bioactivity of most of these marine compounds
has scarcely been studied. The present study overviews the bioactivity of the polysaccharide fucoidan
derived from Fucus vesiculosus brown algae as an antimicrobial agent against Listeria monocytogenes
and Salmonella enterica serovar Typhimurium. The results obtained in vitro in reference medium
reveal a bacteriostatic and bactericidal effect of fucoidan against both pathogens, this bioactivity
being significantly dependent (p-value ≤ 0.05) on the concentration, 5–1000 µg/mL, temperature,
8–37 ◦C, and exposure time, 0–12 days. The results were validated in the formulation of a new
functional pasteurized apple beverage to be commercialized under refrigeration. Fucoidan added at
25–100 µg/mL was highly effective against both pathogens. These results increase knowledge
for the future formulation of new functional beverages that include marine compounds (high
content in fibre, high content in protein; prebiotic and antioxidant properties), additionally revealing
antimicrobial potential.
Keywords: Fucoidan; seaweed; Fucus vesiculosus; Listeria monocytogenes; Salmonella
typhimurium; antimicrobials
1. Introduction
Natural antimicrobials of animal, vegetable, and marine origin have gained importance in recent
years. Specifically, marine organisms have emerged as a sustainable source of products with high
applicability in industry.
Seaweeds are divided into three groups of macroalgae, red (Rhodophyta), brown (Phaeophyta),
and green (Chlorophyta), depending on their nutrient and chemical composition. In particular, brown
seaweeds (e.g., Laminaria digitata, Ascophyllum nodosum, Fucus vesiculosus, Macrocystis pyrifera, Sargassum
fusiforme, Undaria pinnatifida) have a long history of consumption in Japan, Korea, and south-east Asian
countries [1,2]. Brown algae have been consumed since ancient times in China, and their benefits have
been associated with one of the highest ratios of longest-living people in the world (34 centenarians
for every 100,000 inhabitants) [3]. Owing to the highly nutritious composition of these organisms,
with their high protein content, high concentration of polysaccharides, natural richness in minerals,
polyunsaturated fatty acids (PUFA), and vitamins; and their high content of bioactive molecules,
brown algae are being studied in depth as edible vegetables to be distributed to general consumers,
both as raw products and as ingredients obtained by extracting specific compounds [4].
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The search for novel ingredients to increase the healthy potential of ready-to-eat (RTE) products
is increasing in the food market. Sustainable ingredients that are capable of increasing the fibre content
of the final product or improving the prebiotic qualities of these newly designed foods are now being
investigated [5]. Moreover, the search for ways of increasing the protein content of formulations
targeted at infants and the elderly is an additional stimulus for the formulation of new products [3,6].
Specific bioactivities exerted by brown algae compounds place this group in the spotlight for
the discovery of natural ingredients with anti-cancer potential, anti-inflammatory, antioxidant, and
antimicrobial activities, and satiating, prebiotic, and anti-obesity properties [7–11].
Given the need to find effective alternative antimicrobials against antibiotic-resistant bacteria,
many components of brown algae have been investigated. Nowadays, phlorotannins, PUFA,
polysaccharides, proteins, and peptides are presented as effective antimicrobial agents against
Gram-positive and Gram-negative bacteria, yeasts, and even viruses [11–13].
Sulfated polysaccharides (e.g., alginic acids, laminarins, and fucoidans) in brown algae,
representing 5–40% of the dry weight of the raw material, have been successfully explored for
pharmaceutical and dietary applications [14]. Fucoidan is a term used for fucose-rich polysaccharides
found in the fibrillar cell walls and intercellular spaces of brown seaweeds [10]. These sulfated
fucose polysaccharides are generally built of a backbone of (1→3)- and (1→4)-linked α-l-fucopyranose
residues (from 100 to 1600 kDa molecular weight). The antibacterial activity of fucoidan has been
demonstrated against some clinical pathogens, such as Staphylococcus aureus, Escherichia coli, and
Helicobacter pylori [15,16].
Glycoprotein receptors present on the cell surface of polysaccharides appear to be responsible
for the antibacterial action of fucoidan, owing to their ability to bind with compounds in the bacterial
cell wall, cytoplasmic membrane, and DNA [13,17]. In spite of fucoidan’s promising antimicrobial
potential, its antibacterial capability against foodborne pathogens has scarcely been assessed [18].
The aim of the present study is to evaluate the effectiveness of fucoidan from Fucus vesiculosus
as a preservative agent in a pasteurized apple juice-based beverage to be marketed under
refrigeration. To achieve this purpose, firstly, several fucoidan concentrations and incubation
conditions (temperature and exposure time) will be assayed in reference medium against two of
the most important foodborne pathogens, Listeria monocytogenes and Salmonella enterica serovar
Typhimurium [19,20]. The final objective is to contribute to increasing current knowledge in the
validation of the applicability of this ingredient with functional (prebiotic and antioxidant) and
technological (preservative) properties in food.
2. Material and Methods
2.1. Listeria Monocytogenes
The present study was carried out using the strain Listeria monocytogenes CECT 911 provided
by the Spanish Culture Type Collection (CECT, PATERNA, Spain). The lyophilized culture was
revived according to the instructions provided by the CECT. Briefly, the lyophilized bacterial content
provided in a capsule was diluted in 0.2 mL of Tryptic Soy Broth (TSB) (Scharlab, Barcelona, Spain)
and afterwards transferred to a sterile flask containing 10 mL of TSB. The flask was incubated at 37 ◦C
for 30 min. The culture was then incubated in a flask of 400 mL sterile TSB for 16 h at 37 ◦C, with
constant stirring (200 rpm), until the stationary phase was obtained. Cells were recovered by two
centrifugation steps (4000× g, 15 min, 4 ◦C), with removal of the supernatant each time. Recovered
cells were resuspended in sterile TSB supplemented with 20% glycerol [1:1]. A stock culture was
prepared and maintained frozen at −80 ◦C in 2 mL cryovials. The final concentration of the stock was
5 ± 0.8 × 109 CFU/mL.
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2.2. Salmonella Enterica Serovar Typhimurium
A pure culture of S. typhimurium (CECT 443) was provided freeze-dried by the Spanish Type
Culture Collection. After rehydration in 10 mL of Tryptic Soy Broth (TSB) (Scharlab Chemie, Barcelona,
Spain), the culture was transferred to 500 mL of TSB and incubated at 37 ◦C with continuous shaking
(200 rpm) for 14 h to obtain cells in a stationary growth stage according to the method previously
described by Saucedo-Reyes et al. [21]. The cells were centrifuged twice at 4000× g at 4 ◦C for 15 min
and then resuspended in TSB. After centrifugation, the cells were recovered and resuspended in
20 mL of TSB with 20% glycerol. The bacterial suspension was dispensed in 2 mL vials with a final
concentration of 108 CFU/mL. The 2 mL samples were immediately frozen and stored at −80 ◦C until
needed for the antimicrobial studies.
2.3. Fucoidan Suspension Preparation
Fucoidan from the Fucus vesiculosus species belonging to the Phaeophyceae group (brown algae)
was provided by Sigma-Aldrich (Sigma-Aldrich Chemie GmbH, Buchs, Switzerland) as an odourless
white powdered product with purity ≥95% (reference number F8190-500).
Suspensions containing fucoidan at different concentrations were prepared using Mueller Hinton
Broth (MHB) (Scharlab, Barcelona, Spain) as reference medium. A stock solution was prepared
containing 5000 µg/mL of fucoidan in MHB. The suspension was sterilized by filtration (Minisart
0.20 µm filters; reference 16534-K) (Sigma-Aldrich Inc., St. Louis, USA). The stock solution was
divided into aliquots and maintained at −20 ◦C to guarantee the homogeneity of the preparations in
independent work sessions. Tubes containing 5, 10, 25, 50, 100, 200, and 1000 µg/mL of fucoidan were
prepared in sterile MHB in triplicate. Tubes not supplemented with fucoidan, containing only MHB,
were also prepared.
2.4. Inoculum and Incubation Conditions
The suspensions supplemented/not supplemented with fucoidan were inoculated with
L. monocytogenes and S. typhimurium at a final concentration of 4.5 × 104 CFU/mL.
To monitor possible side contaminations during the assay period, a battery of non-inoculated tubes
(blank samples) was also prepared, supplemented/not supplemented with fucoidan. Suspensions
were incubated at the optimum growth temperature of the bacteria, 37 ◦C, and also at 8 ◦C, a slight
abuse refrigeration temperature (worst scenario corresponding to a cold chain breakage) with high
risk for pasteurized products. The incubation period was 7 days at 37 ◦C, and 12 days at 8 ◦C.
2.5. Growth Kinetic Study under Fucoidan Exposure
The growth behaviour of the bacteria was recorded by means of spectrophotometric measurements
(OD550 nm) and plate count [7]. Aliquots were taken regularly, both from samples incubated at 37 ◦C (0,
1, 2, 3, 5, 7 days) and from samples incubated at 8 ◦C (0, 1, 2, 3, 5, 7, 12 days), and spectrophotometric
and CFU/mL quantitative values were recorded. Blank samples were used as control in the OD
measurements. The suspensions were monitored during the complete incubation period to determine
the stability of each of the formulated matrices under the conditions studied.
Serial dilutions in Buffered Peptone Water (BPW) (Scharlab, Barcelona, Spain) (1:1000 (w/v)) were
made from suspensions during the period studied, and seeded on Tryptic Soy Agar (TSA) (Scharlab
S.A., Barcelona, Spain) plates in duplicate. The plates were incubated at 37 ◦C for 48 h prior to the
bacterial count (CFU/mL). All the assays were carried out in triplicate on three separate days.
The growth/inhibition results obtained for L. monocytogenes and S. typhimurium under exposure
to fucoidan were represented as the decimal log of viable cells (log10 (Nf /N0), Nf being the number
of viable cells at each point in time in CFU/mL, and N0 the initial CFU/mL at t = 0 days) versus the
incubation time (days), to determine the bacteriostatic and/or bactericidal effect of this compound.
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2.6. Formulation of a New Functional Apple Juice Beverage
A new prebiotic apple juice beverage (pH = 4.3) was formulated, including fucoidan at several
concentrations, to validate the effectiveness of fucoidan in a real food matrix. Suspensions of fucoidan
at 25, 100, and 1000 µg/mL were prepared in UHT apple juice to determine the effectiveness of
fucoidan in this simple substrate. Supplemented/non-supplemented matrices were inoculated
with L. monocytogenes and S. typhimurium to obtain a final concentration of 5 × 104 CFU/mL.
The non-supplemented apple juice was considered as the control sample. The non-supplemented and
non-inoculated apple juice was considered as the blank sample.
2.7. Statistical Analysis of Data
An ANOVA analysis was carried out to determine statistically significant differences
(p-value ≤ 0.05) between the growth/inhibition/reduction of bacterial levels under the conditions
studied, taking into account the variables included in the present study: fucoidan concentration
(µg/mL), temperature (◦C) and exposure time (days). All the statistical analyses were carried out
using Statgraphics Centurion XV software (Statpoint Technologies Inc., Warrenton, VA, USA).
3. Results
3.1. Antimicrobial Potential of Fucoidan against L. monocytogenes
Figure 1 presents the growth kinetic results from the incubation studies at 37 and 8 ◦C in reference
MHB medium supplemented/not supplemented with fucoidan. As can be seen graphically, at the
slight abuse refrigeration temperature L. monocytogenes was able to grow to a maximum of 1.06 ± 0.15
log cycle in MHB, during the incubation period of 12 days.
The addition of fucoidan at low concentrations in the range 5–25 µg/mL had no bacteriostatic
or bactericidal effect in the control of this pathogen. When the concentration of fucoidan was
increased to 50 µg/mL, a bacteriostatic effect was exerted close to 0.75 log cycles (8 ◦C, 7 days).
Higher 100–1000 µg/mL fucoidan concentrations were bactericidal (0.66–1.12 log cycles reduction)
after 12 days of cell exposure at 8 ◦C.
At the optimum growth temperature of the bacterium, fucoidan showed both a bacteriostatic and
a bactericidal effect against L. monocytogenes, depending on the concentration added (p-value ≤ 0.05)
and the exposure time considered (p-value ≤ 0.05). Fucoidan concentrations of 5, 25, and 50 µg/mL
showed a bacteriostatic effect against L. monocytogenes after 5 days of incubation, inhibiting growth
of this pathogen by up to 1.62 ± 0.08 log cycle with respect to the control. When the exposure time
increased, during incubation for 5 to 7 days at 37 ◦C, the antimicrobial potential of the lowest fucoidan
concentrations increased significantly (p-value ≤ 0.05). The 5 µg/mL fucoidan concentration was
effective in inhibiting the growth of the pathogen to a maximum of 1.95± 0.06 log cycles after 7 days of
exposure. Concentrations in the range 25–50 µg/mL became bactericidal, reducing the initial bacterial
levels by nearly 0.40 log cycles, after 7 days of incubation at 37 ◦C.
The highest concentrations of fucoidan, 100, 200, and 1000 µg/mL, showed a bactericidal effect
against L. monocytogenes even after only 24 h of incubation at 37 ◦C. However, no significant differences
were observed in the bactericidal effect attributable to fucoidan in the concentration range studied
100–1000 µg/mL. Moreover, no significant increase in the bactericidal effect due to an increase in
exposure time was observed in this concentration range (from 0.51 log cycles bacterial reduction after
24 h of incubation to 0.62 log cycles reduction after 7 days of incubation).
Previous studies carried out by Lee et al. [22] attributed a high antimicrobial potential to fucoidan
against Gram-positive and Gram-negative bacteria commonly present in the oral cavity (Streptococcus
mutans, Fusobacterium nucleatum, and Porphyromonas gingivalis, among others). The bacteriostatic
potential of fucoidan against these bacteria was in the range of 150–500 µg/mL. Fucoidan showed a
bactericidal effect against oral cavity bacteria in the range of 250–1000 µg/mL. Similar results were
reported by Choi et al. [12], with MIC and MBC equal to 128 µg/mL and 256–512 µg/mL, respectively,
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against several strains of S. aureus (Gram-positive). According to our results, a higher antimicrobial
potential could be attributed to fucoidan derived from Fucus vesiculosus against the Gram-positive
foodborne pathogen L. monocytogenes, the MIC at 37 ◦C being 5 µg/mL, and the MBC value 100 µg/mL
at the same incubation temperature (see Table 1).
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Figure 1. Kinetic results (log (CFU/mL) versus time (days)) obtained in the determination of the
in vitro antimicrobial potential of fucoidan against Listeria monocytogenes in reference medium, Mueller
Hinton Broth (MHB). (A) 8 ◦C (12 days); (B) 37 ◦C (7 days).
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Table 1. Fucoidan bacteriostatic and bactericidal potential against Listeria monocytogenes and Salmonella typhimurium in reference medium and in an apple
juice-based beverage.
Temperature
37 ◦C 8 ◦C
Substrates µg/mL Exposure time (days) Log10 cycles µg/mL Exposure time (days) Log cycles
Listeria monocytogenes
Mueller Hinton Broth (MHB)
MIC 5 5 1.55 ± 0.04 100 7 0.83 ± 0.08
MBC 100 1 0.61 ± 0.03 50 12 0.89 ± 0.13
Apple juice µg/mL Exposure time (days) Log10 cycles µg/mL Exposure time (days) Log cycles
MIC - - - - - -
MBC - - - 1000 12 0.70 ± 0.06
Salmonella typhimurium
Mueller Hinton Broth (MHB)
MIC 1000 7 1.08 ± 0.23 - - -
MBC - - - 10 2 1.25 ± 0.15
Apple juice µg/mL Exposure time (days) Log10 cycles µg/mL Exposure time (days) Log cycles
MIC - - - - - -
MBC - - - 25 2 1.52 ± 0.08
MIC: Minimum inhibitory concentration (µg/mL); MBC: Minimum bactericidal concentration (µg/mL).
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3.2. Antimicrobial Potential of Fucoidan against S. typhimurium
The results of S. typhimurium growth inhibition and inactivation due to the effect of fucoidan
are presented in Figure 2. As can be seen graphically, at low incubation temperature fucoidan
concentrations in the range 5–1000 µg/mL were all effective in inhibiting bacterial growth, and even
more in inactivating S. typhimurium, depending on the fucoidan concentration applied and the exposure
time considered (p-value ≤ 0.05).Beverages 2018, 4, x FOR PEER REVIEW  9 of 15 
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initial counts were reduced completely. 
At the optimum growth temperature of the bacterium, 37 °C, fucoidan derived from Fucus 
vesiculosus showed a bacteriostatic effect, slowing down the growth rate of the bacterium and, 
consequently, the final levels during incubation, in comparison with the S. typhimurium counts 
observed in MHB control medium. Fucoidan concentrations in the range 5–50 µg/mL revealed a 
maximum bacteriostatic potential corresponding to 0.80 log cycles of bacterial growth inhibition after 
7 days of incubation at 37 °C. The higher the fucoidan concentration added to the medium, the higher 
the bacteriostatic effect (p-value ≤ 0.05) exerted by this bioactive compound. Suspensions of fucoidan 
in the range 100–1000 µg/mL were effective in inhibiting S. typhimurium growth by 1.08 to 1.22 log 
cycle, even in the first hours of exposure (24–48 h). During the incubation period, the longer the 
Figure 2. Kinetic results (log (CFU/mL) versus time (days)) obtained in the determination of the in vitro
antimicrobial potential of fucoidan against Salmonella typhimurium in reference medium, Mueller Hinton
Broth (MHB). (A) 8 ◦C (12 days); (B) 37 ◦C (7 days). Values below the detection limit are shown as not
detected (n.d.).
In the non-supplemented MHB control medium, S. typhimurium was unable to grow at 8 ◦C,
and the initially inoculated levels decreased progressively during the refrigeration period (0.50 log
cycles after 7 days). The lowest concentration of fucoidan, 5 µg/mL, showed a bactericidal effect
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close to 1 log10 cycle against S. typhimurium after only 48 h of refrigerated incubation. This effect
increased as the exposure time continued, reaching a maximum reduction of 1.64 log cycles after
5 days of exposure at this temperature. Fucoidan added at a concentration of 10 µg/mL reduced
the S. typhimurium counts by nearly 1.84 log cycles after 48 h of refrigerated exposure, achieving
bactericidal effects close to 2.50 log10 cycles after only 5 days of incubation at this temperature.
Fucoidan concentrations in the range 5–10 µg/mL were effective in reducing the initial S. typhimurium
counts to undetectable levels after 7 days of refrigerated incubation, which corresponds to a significant
bactericidal effect close to 5 log cycles. Fucoidan concentrations in the range 50–1000 µg/mL revealed
a higher antimicrobial potential against this Gram-negative pathogen. Bacterial reductions in the
range 0.65–1.5 log cycles were achieved after only 24 h of refrigerated incubation in MHB medium
supplemented with 50–1000 µg/mL of fucoidan (see Figure 2).
After 5 days of incubation there was a reduction of 2.5 log cycles owing to exposure to
50–1000 µg/mL of fucoidan, and after 7 days of incubation in these supplemented matrices the
S. typhimurium initial counts were reduced completely.
At the optimum growth temperature of the bacterium, 37 ◦C, fucoidan derived from Fucus
vesiculosus showed a bacteriostatic effect, slowing down the growth rate of the bacterium and,
consequently, the final levels during incubation, in comparison with the S. typhimurium counts observed
in MHB control medium. Fucoidan concentrations in the range 5–50 µg/mL revealed a maximum
bacteriostatic potential corresponding to 0.80 log cycles of bacterial growth inhibition after 7 days
of incubation at 37 ◦C. The higher the fucoidan concentration added to the medium, the higher the
bacteriostatic effect (p-value ≤ 0.05) exerted by this bioactive compound. Suspensions of fucoidan in
the range 100–1000 µg/mL were effective in inhibiting S. typhimurium growth by 1.08 to 1.22 log cycle,
even in the first hours of exposure (24–48 h). During the incubation period, the longer the exposure
time, the greater the effectiveness of 1000 µg/mL as a bacteriostatic agent (p-value ≤ 0.05), inhibiting
bacterial growth by a maximum of 1.37 ± 0.28 log cycles in comparison to the growth observed in the
control suspensions (MHB without fucoidan supplementation).
It can be concluded that the antimicrobial potential of fucoidan against S. typhimurium is
significantly influenced by the variables studied (fucoidan concentration, incubation temperature, and
exposure time) (p-value ≤ 0.05), affecting the antimicrobial effectiveness of this compound. However,
no significant increase in the antimicrobial capability of fucoidan was detected when the concentration
added was increased from 100 to 1000 µg/mL.
3.3. Effectiveness of Fucoidan Derived from Fucus Vesiculosus against L. monocytogenes and S. typhimurium
in a Newly Formulated Apple Juice Beverage
Given the observed bacteriostatic and bactericidal potential of fucoidan against L. monocytogenes
and S. typhimurium in reference medium, the effectiveness of this compound was assessed in an apple
juice-based beverage to determine the applicability of this ingredient to achieve functional (prebiotic
and antioxidant) [5,23] and technological (preservative) objectives. Fucoidan was included in the
formulation of the new beverage at concentrations of 25, 100, and 1000 µg/mL. Sterile UHT apple juice
was used as a basic food matrix (pH = 4.3). The suspensions studied were maintained under the most
disadvantageous conditions: slight abuse refrigeration temperature, 8 ◦C, for 12 days.
Figure 3 shows the results of growth/no growth of the bacterium in the food substrate studied
when exposed to fucoidan. As can be seen graphically, L. monocytogenes was unable to grow in apple
juice during the incubation period, despite which it remained viable at levels close to the initially
inoculated values.
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Figure 3. Antimicrobial potential of fucoidan from Fucus vesiculosus against Listeria monocytogenes (A)
and Salmonella typhimurium (B) in a novel functional apple juice beverage stored at 8 ◦C for 12 days.
The addition of fucoidan at a concentration level of 25 µg/mL did not reveal any bactericidal
effect against L. monocytogenes. Concentrations in the range 100–1000 µg/mL showed a low bactericidal
effect; the longer the exposure time, the higher the bacterial reduction (p-value≤ 0.05). Fucoidan added
to apple juice at a concentration level of 100 µg/mL reduced the bacterial population by 0.40 ± 0.02
log cycles after 12 days of incubation. A fucoidan concentration of 1000 µg/mL proved effective in
reducing the bacterial load in the food matrix to 0.70 ± 0.01 log cycles after an exposure time of 12
days at 8 ◦C.
In the non-supplemented beverage, S. typhimurium was reduced slightly (1 log cycle) during
the 8 ◦C incubation period, probably owing to two factors, the low pH and the low temperature
conditions. However, after 48 h of incubation under these refrigerated acid conditions, the bacterial
counts stabilized and remained in a viable-culturable stage until the final storage period. These results
agree with those previously presented by Lee et al. [24] and Alvarez-Ordóñez et al. [25] regarding the
acid-tolerance capability of S. typhimurium cells (CECT 443) in stationary phase incubated at different
temperatures. With regard to the antimicrobial potential of fucoidan against S. typhimurium in this
novel beverage, it was observed that all the concentrations studied were able to reduce the initially
inoculated bacterial levels completely. The bactericidal potential of 25 µg/mL of fucoidan was close to
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1.5 log cycles after 2 days of exposure, and was close to 3.5. log cycles with 1000 µg/mL under the
same incubation conditions (2 days, 8 ◦C). Significant differences in antimicrobial potential in the apple
beverage were observed between the fucoidan concentrations of 100 and 1000 µg/mL (p-value ≤ 0.05);
the higher the concentration added, the shorter the exposure time required to completely inactivate S.
typhimurium in the food matrix. After 5 days of exposure incubated at 8 ◦C, the 1000 µg/mL fucoidan
concentration was effective in reducing the S. typhimurium initial counts by 4 log cycles. Refrigerated
incubation for 7 days was required to reduce the initially inoculated S. typhimurium bacterial levels
completely when fucoidan was added at 100 µg/mL, and 25 µg/mL was completely effective in
reducing S. typhimurium below detectable levels after incubation for 12 days at 8 ◦C.
Table 1 includes the fucoidan values that correspond to the minimum inhibitory concentrations
(MIC) and minimum bactericidal concentrations (MBC) against the pathogens studied. From the
results obtained, it can be concluded that S. typhimurium was more sensitive to the effect of fucoidan
than L. monocytogenes.
L. monocytogenes is more sensitive to the antimicrobial effect of fucoidan at the optimum
growth incubation temperature, and is more resistant to the antimicrobial bioactivity of fucoidan
at refrigeration temperature. This behavioural response could be connected with the activation by the
bacterium, under adverse external conditions (such as low temperatures or acidity, among others), of
protective mechanisms that protect the bacterial cells against the effect of fucoidan [26]. Changes in
membrane permeability could interfere with the effect of fucoidan, since one of the main actions
of this compound is exerted at membrane surface level, by binding with specific receptors [13,17].
In this case, the ability of the bacterium to alter membrane permeability in order to increase tolerance
to low temperatures could also be connected with interference with the activity of fucoidan under
refrigerated conditions. Similar results were obtained by Belda-Galbis, Leufvén, Martínez, Rodrigo [27]
and Belda-Galbis, Jiménez-Carretón, Pina-Pérez, Martínez, Rodrigo [28] regarding the antimicrobial
potential of other natural compounds, açaí and carvacrol, against Listeria innocua, and they were also
more effective at the optimum growth temperature of Listeria spp. (37 ◦C).
On the other hand, S. typhimurium is able to grow slightly at 37 ◦C even under the effect of
fucoidan, and a concentration of 100 µg/mL is required to inhibit the bacterial growth by nearly 1
log cycle. However, at refrigeration temperature, the effect of fucoidan against this Gram-negative
pathogen is very strong, with a MBC of 10 µg/mL, reducing the initial inoculated bacterial counts by
1.25 ± 0.15 log cycles. In the apple beverage, 25 µg/mL is the MBC to achieve nearly 1 log cycle of S.
typhimurium reduction in only 48 h at 8 ◦C.
In the case of exposure of L. monocytogenes to fucoidan, concentration levels ≥50 µg/mL at 8 ◦C
act only as growth control factors against this pathogen. From a comparison of the results of the
effectiveness of fucoidan in MHB (pH = 6.8) and in apple juice (pH = 4.3) at a refrigeration temperature
of 8 ◦C, it can be concluded that the antimicrobial potential of fucoidan against L. monocytogenes is
higher in the food matrix than in the reference medium. This could be due to the combined effect of
low-pH and addition of fucoidan, both acting as hurdles against proliferation of L. monocytogenes.
With regard to the antimicrobial potential of fucoidan against S. typhimurium, this compound
also showed a greater antimicrobial effect when it was included in the formulation of the new acidic
functional apple beverage. Inactivation levels close to 2 log cycles were achieved after 48 h of bacterial
exposure to a concentration of 100 µg/mL of fucoidan in the beverage, whereas 5 days of exposure
were required in the reference medium to achieve the same level of microbial reduction.
From a technological point of view, the addition of fucoidan in a concentration range of
100–1000 µg/mL to this acidic apple-based beverage is presented as an effective measure for the control
of L. monocytogenes, these levels being effective to guarantee reduction of the growing population by
up to a maximum of nearly 1 log10 cycle during the period of commercialization of this pasteurized
product (12 days under refrigeration). Furthermore, the quality of the organoleptic properties of the
apple juice remains intact after the addition of fucoidan (25–1000 µg/mL). To date, little information
has been published about the physico-chemical changes induced in food matrices as a result of the
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addition of fucoidan extracts [29]. The physico-chemical and functional (antioxidant, gastroprotective,
anti-inflammatory) properties of fucoidan depend on its molecular weight, structure, and concentration;
and they vary depending on the source of the fucoidans, the harvest period, and the extraction
methods [30]. Therefore, the impact of fucoidan extracts on the sensory properties of this novel food
formulation will also depend on these specific features of fucoidan, and it should be optimized for
the matrix in which the fucoidan is incorporated. The main physico-chemical changes in apple juice
expected as a result of the addition of fucoidan could be increases in the lightness (L value), viscosity
(mPas), and turbidity of the liquid at high concentrations, accompanied by increases in the total soluble
solids and the antioxidant potential of the juice [31].
Furthermore, from a functional point of view, according to the work of Hwang et al. [23], the use
of both low and high molecular weight fucoidans at concentrations in the range of 50–100 µg/mL has a
prebiotic potential, stimulating the growth of Bifidobacterium lactis in an in vitro model using Caco-2 cells.
The adhesion of Bifidobacterium spp. cells to the gastrointestinal tract is increased by the intervention
of fucoidans, which act as key determinants in the initialization of probiotic immunomodulatory
activity [23]. Moreover, the antioxidant potential of fucoidans has been well demonstrated in vitro and
in vivo, and fucoidan has even been incorporated in real food matrices, such as meat products [29].
4. Conclusions
The present study shows the effectiveness of fucoidan derived from Fucus vesiculosus brown
algae as a natural antimicrobial against L. monocytogenes and S. typhimurium. This compound acts
with a bacteriostatic and bactericidal effect at 37 ◦C against L. monocytogenes, depending on the
concentration added and the exposure time. At lower temperatures, close to refrigeration, when
added at concentrations ≥100 µg/mL, after 7 days of exposure fucoidan only exerted a bacteriostatic
potential. Higher antimicrobial effectiveness of fucoidan was observed against S. typhimurium, with a
MBC of 25 µg/mL in a novel apple-based beverage.
The results obtained in the present study open up new possibilities for research on the use
of this natural compound as a sustainable bioactive ingredient to be added for the purpose of
food preservation.
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